tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
3.030USD
-0.030-0.98%
Close 02/06, 16:00ETQuotes delayed by 15 min
5.00MMarket Cap
LossP/E TTM

Sonoma Pharmaceuticals Inc

3.030
-0.030-0.98%

More Details of Sonoma Pharmaceuticals Inc Company

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc Info

Ticker SymbolSNOA
Company nameSonoma Pharmaceuticals Inc
IPO dateJan 26, 2007
CEOTrombly (Amy)
Number of employees168
Security typeOrdinary Share
Fiscal year-endJan 26
Address5445 Conestoga Court, Suite 150
CityBOULDER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80301
Phone18007599305
Websitehttps://sonomapharma.com/
Ticker SymbolSNOA
IPO dateJan 26, 2007
CEOTrombly (Amy)

Company Executives of Sonoma Pharmaceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-1.00%
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-1.00%
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Human Care
5.12M
91.29%
Animal Care
488.00K
8.71%
By RegionUSD
Name
Revenue
Proportion
Europe
2.15M
38.38%
United States
1.45M
25.86%
Asia
1.06M
18.86%
Latin America
532.00K
9.49%
Rest of the world
415.00K
7.41%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Human Care
5.12M
91.29%
Animal Care
488.00K
8.71%

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.11%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
McKinley Carter Wealth Services, Inc.
0.66%
Thornton (Bruce)
0.45%
Other
95.74%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.11%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
McKinley Carter Wealth Services, Inc.
0.66%
Thornton (Bruce)
0.45%
Other
95.74%
Shareholder Types
Shareholders
Proportion
Investment Advisor
2.86%
Individual Investor
1.24%
Investment Advisor/Hedge Fund
1.04%
Hedge Fund
0.09%
Research Firm
0.05%
Other
94.72%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
39
57.27K
3.37%
-75.31K
2025Q3
34
106.22K
6.24%
+25.12K
2025Q2
39
61.63K
4.65%
-24.83K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
20.87K
1.23%
+2.09K
+11.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
17.62K
1.04%
--
--
Sep 30, 2025
DRW Securities, LLC
17.07K
1%
+17.07K
--
Sep 30, 2025
Thornton (Bruce)
7.72K
0.45%
-1.00
-0.01%
Jul 08, 2025
Trombly (Amy Moss)
7.68K
0.45%
--
--
Jul 08, 2025
Dvonch (Jerome J)
4.23K
0.25%
-1.00
-0.02%
Jul 08, 2025
Tower Research Capital LLC
1.54K
0.09%
+536.00
+53.60%
Sep 30, 2025
Dal (Poggetto John)
910.00
0.05%
+910.00
--
Jun 20, 2024
Global Retirement Partners, LLC
438.00
0.03%
+438.00
--
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
KeyAI